Your browser doesn't support javascript.
loading
Genetic variant in miR-21 binding sites is associated with colorectal cancer risk.
Xie, Lisheng; Li, Shuwei; Jin, Jing; He, Lei; Xu, Kaili; Zhu, Lingjun; Du, Mulong; Liu, Yanqing; Chu, Haiyan; Zhang, Zhengdong; Wang, Meilin; Shi, Danni; Gu, Dongying; Ni, Min.
Affiliation
  • Xie L; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Li S; The Key Laboratory of Modern Toxicology of Ministry of Education, Department of Genetic Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Jin J; Department of Infection Control, Zhongshan Hospital Qingpu Branch, Fudan University, Shanghai, China.
  • He L; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Xu K; The Key Laboratory of Modern Toxicology of Ministry of Education, Department of Genetic Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Zhu L; Department of Cardiovascular Center, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Du M; Department of Colorectal Surgery, The Third Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Liu Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Chu H; The Key Laboratory of Modern Toxicology of Ministry of Education, Department of Genetic Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Zhang Z; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Wang M; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Shi D; Department of Biostatistics, Nanjing Medical University, Nanjing, China.
  • Gu D; The Core Facilities, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Ni M; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
J Cell Mol Med ; 23(3): 2012-2019, 2019 03.
Article in En | MEDLINE | ID: mdl-30569605
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Binding Sites / Colorectal Neoplasms / Polymorphism, Single Nucleotide / MicroRNAs Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2019 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Binding Sites / Colorectal Neoplasms / Polymorphism, Single Nucleotide / MicroRNAs Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2019 Document type: Article Affiliation country: China